Reporting owner · CIK 0001304395
Bitterman Robert J
Visual SEC Form 4 history across 1 companies, 3 transactions and 3 filings.
CHAIR, PRES, CEOChairman, Pres. & CEOPhio Pharmaceuticals Corp.
Open-market mix
100%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.
- Window follows the rest of the summary (all-history or last 3 months).
- Only buys with a resolved price context are counted.
- Includes both positive and negative outcomes; gains and losses net out at the per-buy level.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Dec 25
$5.2K
Feb 26
$0
Aug 26
$10.6K
Transaction texture
Ownership and ticket size
Average P/S size$7.9K
Median P/S size$7.9K
Direct3
Indirect0
Aug 18, 2026buy
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
buy at Phio Pharmaceuticals Corp. on Aug 18, 2026 valued at $10,600.
Review SEC filingLatest sale
No open-market insider sale is available.
Associated companies
Visual map of known reporting history
Latest insider transactions
Form 4 filings from available history. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #10936 | PHIO | Bitterman Robert J | CHAIRPRESCEO | buy | 10.0k | $1.06M | P | 08/19 | 08/18 |
| #54002 | PHIO | Bitterman Robert J | CHAIRPRESCEO | grant | 120k | $0 | A | 02/06 | 02/05 |
| #17102 | PHIO | Bitterman Robert J | CHAIRPRESCEO | buy | 5.00k | $515k | P | 01/02 | 12/31/2025 |
Bitterman Robert J Insider Activity FAQ
SEC Form 4 context
Who is Bitterman Robert J?
Bitterman Robert J is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001304395.
Which companies has Bitterman Robert J reported transactions for?
Phio Pharmaceuticals Corp.
When was Bitterman Robert J's latest insider buy?
buy at Phio Pharmaceuticals Corp. on Aug 18, 2026 valued at $10,600.
When was Bitterman Robert J's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.